Patrick Derigs

4PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

|Jun 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCT.

|Aug 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study.

Patrick Derigs, Maria-Luisa Schubert, Peter Dreger

|Dec 03, 2020
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.

Patrick Derigs, Aleksandar Radujkovic, Maria-Luisa Schubert

Pageof 1

Frequent Collaborators

3 joint publications

Carsten Müller-Tidow

2 joint publications

Schayan Yousefian

2 joint publications

Simon Haas

2 joint publications

Michael Schmitt